0 CHECKOUT

Injectable Drug Delivery to 2022

  • ID: 3063960
  • January 2015
  • Region: Global
  • Greystone Associates
Drugs, Devices, Markets and Forecasts

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

- Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication

- Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues

- Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies

- Forecasts Injectable drug product demand by indication and therapy to 2022

- Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations

Note: Product cover images may vary from those shown

1. Executive Summary

2. Injectable Drug Delivery Market Dynamics
- The Injectable Drug Ecosystem
- Injectable Drug Demand Drivers
- Drug Development Factors
- Market Factors
- Technology Factors
- Competitive Landscape
- Autoinjectors
- Needle-free Injectors
- Pen Injectors
- Prefilled Syringes
- Safety Syringes
- Risks and Opportunities

3. Injectable Drug Device Selection Criteria
- Stability and Material Selection Issues
- Single vs Multi-Dose Devices
- Lyophilized Drugs/Reconstitution
- Syringe Safety/Sharps Protection
- Needle Configuration Strategies
- Disposable Drug Cartridges
- Human Engineering/Ergonomics
- Branding/Private Labeling

4. Injectable Drug Delivery – Device Segments

5. Autoinjectors
- Autoinjector-specific Selection Factors
- Part Counts and Device Cost
- Safety Features
- Needle Shielding
- Needle Insertion Depth
- Failsafe Activation
- Dose Inspection/Injection Confirmation
- Autoinjector Device Categories
- Reusable Autoinjectors
- Disposable Autoinjectors
- Product Specific Autoinjectors
- Drugs and Therapeutic Segments

6. Needle-free Injectors
- Device Categories
- End User/Practitioner/Mass Immunization Injectors
- Prefilled Disposable Models
- Refillable Cartridge Designs
- Energy Source

7. Pen Injectors
- Pen Injector Device Categories
- Standardized Pen Platforms
- Custom Pen Designs
- Prefilled Pen Cartridges
- Disposable Pens
- Dual Chamber Pens
- Branded Drug/Pen Injector Product by Therapeutic Segment

8. Prefilled Syringes
- Prefilled Syringe Device Categories
- Glass Prefilled Syringes
- Prefillable Glass Syringe Manufacturers and Branded Devices
- Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment
- Plastic Prefilled Syringes
- Branded Prefillable Plastic Syringes
- Drugs and Therapeutic Segments
- Prefillable Safety Syringes
- Prefilled Syringe-specific Selection Factors
- PFS Manufacturing Factors
- Fill-and-Finish Operations

9. Safety Syringes
- Safety Syringe Device Categories
- Prefillable Integrated Safety Syringes
- Non-Prefillable Integrated Safety Syringes

10. Injectable Drug Delivery – Therapeutic Segment Analysis & Forecasts
- Anaphylaxis
- Anticoagulants
- Antivirals
- Autoimmune Diseases
- Emergency Medicine
- Hematopoietics
- Hormone Replacement
- Metabolic Diseases
- Neurology
- Reproductive Health
- Vaccines

11. Injectable Drug Therapeutics - Market Factors
- Regulatory Factors and Issues
- FDA Regulations
- Regulating Combination Products
- Sharps Legislations
- Clinical Trial Factors
- Managed Care and Healthcare Economics

12. Company Profiles

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Bayer AG
  • LEO Laboratories Ltd.
  • Grünenthal GmbH
  • Medtronic, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Pall Corporation